India, April 20 -- image credit- freepik

Mumbai-based SynSmart Rasayan Research and Swiss firm Amporin Pharmaceuticals AG have announced a collaboration to develop breakthrough small molecule therapeutics for the treatment of deadly degenerative diseases.

Under the terms of this collaboration, SynSmart will synthesise a substantial library of novel membrane-protecting molecules at its Mumbai research facility. Upon screening, the collaboration could be extended to follow-on chemistry as well as potential work in ADME-PK areas, with the intention to accelerate the project to candidate selection.

SynSmart is a boutique chemistry CRDMO offering custom synthesis, medicinal chemistry and other services to over 40+ biotech and Big Pharm...